Methamphetamine potentiates HIV-1gp120-induced microglial neurotoxic activity by enhancing microglial outward K+ current

Methamphetamine (Meth) abuse not only increases the risk of human immunodeficiency virus-1 (HIV-1) infection, but exacerbates HIV-1-associated neurocognitive disorders (HAND) as well. The mechanisms underlying the co-morbid effect are not fully understood. Meth and HIV-1 each alone interacts with mi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular and cellular neuroscience 2017-07, Vol.82, p.167-175
Hauptverfasser: Liu, Jianuo, Xu, Enquan, Tu, Guihua, Liu, Han, Luo, Jiangtao, Xiong, Huangui
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 175
container_issue
container_start_page 167
container_title Molecular and cellular neuroscience
container_volume 82
creator Liu, Jianuo
Xu, Enquan
Tu, Guihua
Liu, Han
Luo, Jiangtao
Xiong, Huangui
description Methamphetamine (Meth) abuse not only increases the risk of human immunodeficiency virus-1 (HIV-1) infection, but exacerbates HIV-1-associated neurocognitive disorders (HAND) as well. The mechanisms underlying the co-morbid effect are not fully understood. Meth and HIV-1 each alone interacts with microglia and microglia express voltage-gated potassium (KV) channel KV1.3. To understand whether KV1.3 functions an intersecting point for Meth and HIV-1, we studied the augment effect of Meth on HIV-1 glycoprotein 120 (gp120)-induced neurotoxic activity in cultured rat microglial cells. While Meth and gp120 each alone at low (subtoxic) concentrations failed to trigger microglial neurotoxic activity, Meth potentiated gp120-induced microglial neurotoxicity when applied in combination. Meth enhances gp120 effect on microglia by enhancing microglial KV1.3 protein expression and KV1.3 current, leading to an increase of neurotoxin production and resultant neuronal injury. Pretreatment of microglia with a specific KV1.3 antagonist 5-(4-Phenoxybutoxy)psoralen (PAP) or a broad spectrum KV channel blocker 4-aminopyridine (4-AP) significantly attenuated Meth/gp120-treated microglial production of neurotoxins and resultant neuronal injury, indicating an involvement of KV1.3 in Meth/gp120-induced microglial neurotoxic activity. Meth/gp120 activated caspase-3 and increased caspase-3/7 activity in microglia and inhibition of caspase-3 by its specific inhibitor significantly decreased microglial production of TNF-α and iNOS and attenuated microglia-associated neurotoxic activity. Moreover, blockage of KV1.3 by specific blockers attenuated Meth/gp120 enhancement of caspase-3/7 activity. Taking together, these results suggest an involvement of microglial KV1.3 in the mediation of Meth/gp120 co-morbid effect on microglial neurotoxic activity via caspase-3 signaling. •Meth potentiates gp120-induced microglial neurotoxic activity.•Meth potentiation of gp120 effect on microglia via K+ channel KV1.3 and caspase 3/7 signaling•Present results may imply a potential mechanism for HAND pathogenesis in the era of cART.
doi_str_mv 10.1016/j.mcn.2017.05.009
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5524377</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1044743116301312</els_id><sourcerecordid>1903438868</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-78f697966c862baa9406742a6eb457d0d8f5cb566afb1451426fd68ef61dad5c3</originalsourceid><addsrcrecordid>eNp9kU2L1DAYx4so7rr6AbxIjoK0JmleWgRBFnUXV7yo15AmT2cytElN0nHn25th1mW9eEog_5cnz6-qXhLcEEzE210zG99QTGSDeYNx_6g6J7jndd9S-fh4Z6yWrCVn1bOUdhhjTvv2aXVGO85py8h5dfsV8lbPyxaynp0HtIQMPjudIaGr65812SyE4tp5uxqwaHYmhs3k9IQ8rDHkcOsM0ia7vcsHNBwQ-K32xvnNQ21Y828dLfryBpk1xtLwvHoy6inBi7vzovrx6eP3y6v65tvn68sPN7VhnORadqPoZS-E6QQdtO4ZFpJRLWBgXFpsu5GbgQuhx4EUB6NitKKDURCrLTftRfX-lLuswwzWlOqoJ7VEN-t4UEE79e-Ld1u1CXtVNsRaKUvA67uAGH6tkLKaXTIwTdpDWJMiPW5Z23WiK1JykpZ_pxRhvK8hWB2JqZ0qxNSRmMJcFWLF8-rhfPeOv4iK4N1JAGVLewdRJePAFxgugsnKBvef-D-eEqny</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1903438868</pqid></control><display><type>article</type><title>Methamphetamine potentiates HIV-1gp120-induced microglial neurotoxic activity by enhancing microglial outward K+ current</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Liu, Jianuo ; Xu, Enquan ; Tu, Guihua ; Liu, Han ; Luo, Jiangtao ; Xiong, Huangui</creator><creatorcontrib>Liu, Jianuo ; Xu, Enquan ; Tu, Guihua ; Liu, Han ; Luo, Jiangtao ; Xiong, Huangui</creatorcontrib><description>Methamphetamine (Meth) abuse not only increases the risk of human immunodeficiency virus-1 (HIV-1) infection, but exacerbates HIV-1-associated neurocognitive disorders (HAND) as well. The mechanisms underlying the co-morbid effect are not fully understood. Meth and HIV-1 each alone interacts with microglia and microglia express voltage-gated potassium (KV) channel KV1.3. To understand whether KV1.3 functions an intersecting point for Meth and HIV-1, we studied the augment effect of Meth on HIV-1 glycoprotein 120 (gp120)-induced neurotoxic activity in cultured rat microglial cells. While Meth and gp120 each alone at low (subtoxic) concentrations failed to trigger microglial neurotoxic activity, Meth potentiated gp120-induced microglial neurotoxicity when applied in combination. Meth enhances gp120 effect on microglia by enhancing microglial KV1.3 protein expression and KV1.3 current, leading to an increase of neurotoxin production and resultant neuronal injury. Pretreatment of microglia with a specific KV1.3 antagonist 5-(4-Phenoxybutoxy)psoralen (PAP) or a broad spectrum KV channel blocker 4-aminopyridine (4-AP) significantly attenuated Meth/gp120-treated microglial production of neurotoxins and resultant neuronal injury, indicating an involvement of KV1.3 in Meth/gp120-induced microglial neurotoxic activity. Meth/gp120 activated caspase-3 and increased caspase-3/7 activity in microglia and inhibition of caspase-3 by its specific inhibitor significantly decreased microglial production of TNF-α and iNOS and attenuated microglia-associated neurotoxic activity. Moreover, blockage of KV1.3 by specific blockers attenuated Meth/gp120 enhancement of caspase-3/7 activity. Taking together, these results suggest an involvement of microglial KV1.3 in the mediation of Meth/gp120 co-morbid effect on microglial neurotoxic activity via caspase-3 signaling. •Meth potentiates gp120-induced microglial neurotoxic activity.•Meth potentiation of gp120 effect on microglia via K+ channel KV1.3 and caspase 3/7 signaling•Present results may imply a potential mechanism for HAND pathogenesis in the era of cART.</description><identifier>ISSN: 1044-7431</identifier><identifier>EISSN: 1095-9327</identifier><identifier>DOI: 10.1016/j.mcn.2017.05.009</identifier><identifier>PMID: 28552341</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Cells, Cultured ; Drug abuse ; Female ; HIV Envelope Protein gp120 - metabolism ; HIV protein ; Methamphetamine - pharmacology ; Microglia ; Microglia - metabolism ; Neurodegeneration ; Neurons - metabolism ; Potassium - metabolism ; Rats, Sprague-Dawley ; Signal Transduction - physiology ; Tumor Necrosis Factor-alpha - metabolism ; Voltage-gated K channel</subject><ispartof>Molecular and cellular neuroscience, 2017-07, Vol.82, p.167-175</ispartof><rights>2017 Elsevier Inc.</rights><rights>Copyright © 2017 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-78f697966c862baa9406742a6eb457d0d8f5cb566afb1451426fd68ef61dad5c3</citedby><cites>FETCH-LOGICAL-c451t-78f697966c862baa9406742a6eb457d0d8f5cb566afb1451426fd68ef61dad5c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.mcn.2017.05.009$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28552341$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Jianuo</creatorcontrib><creatorcontrib>Xu, Enquan</creatorcontrib><creatorcontrib>Tu, Guihua</creatorcontrib><creatorcontrib>Liu, Han</creatorcontrib><creatorcontrib>Luo, Jiangtao</creatorcontrib><creatorcontrib>Xiong, Huangui</creatorcontrib><title>Methamphetamine potentiates HIV-1gp120-induced microglial neurotoxic activity by enhancing microglial outward K+ current</title><title>Molecular and cellular neuroscience</title><addtitle>Mol Cell Neurosci</addtitle><description>Methamphetamine (Meth) abuse not only increases the risk of human immunodeficiency virus-1 (HIV-1) infection, but exacerbates HIV-1-associated neurocognitive disorders (HAND) as well. The mechanisms underlying the co-morbid effect are not fully understood. Meth and HIV-1 each alone interacts with microglia and microglia express voltage-gated potassium (KV) channel KV1.3. To understand whether KV1.3 functions an intersecting point for Meth and HIV-1, we studied the augment effect of Meth on HIV-1 glycoprotein 120 (gp120)-induced neurotoxic activity in cultured rat microglial cells. While Meth and gp120 each alone at low (subtoxic) concentrations failed to trigger microglial neurotoxic activity, Meth potentiated gp120-induced microglial neurotoxicity when applied in combination. Meth enhances gp120 effect on microglia by enhancing microglial KV1.3 protein expression and KV1.3 current, leading to an increase of neurotoxin production and resultant neuronal injury. Pretreatment of microglia with a specific KV1.3 antagonist 5-(4-Phenoxybutoxy)psoralen (PAP) or a broad spectrum KV channel blocker 4-aminopyridine (4-AP) significantly attenuated Meth/gp120-treated microglial production of neurotoxins and resultant neuronal injury, indicating an involvement of KV1.3 in Meth/gp120-induced microglial neurotoxic activity. Meth/gp120 activated caspase-3 and increased caspase-3/7 activity in microglia and inhibition of caspase-3 by its specific inhibitor significantly decreased microglial production of TNF-α and iNOS and attenuated microglia-associated neurotoxic activity. Moreover, blockage of KV1.3 by specific blockers attenuated Meth/gp120 enhancement of caspase-3/7 activity. Taking together, these results suggest an involvement of microglial KV1.3 in the mediation of Meth/gp120 co-morbid effect on microglial neurotoxic activity via caspase-3 signaling. •Meth potentiates gp120-induced microglial neurotoxic activity.•Meth potentiation of gp120 effect on microglia via K+ channel KV1.3 and caspase 3/7 signaling•Present results may imply a potential mechanism for HAND pathogenesis in the era of cART.</description><subject>Animals</subject><subject>Cells, Cultured</subject><subject>Drug abuse</subject><subject>Female</subject><subject>HIV Envelope Protein gp120 - metabolism</subject><subject>HIV protein</subject><subject>Methamphetamine - pharmacology</subject><subject>Microglia</subject><subject>Microglia - metabolism</subject><subject>Neurodegeneration</subject><subject>Neurons - metabolism</subject><subject>Potassium - metabolism</subject><subject>Rats, Sprague-Dawley</subject><subject>Signal Transduction - physiology</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><subject>Voltage-gated K channel</subject><issn>1044-7431</issn><issn>1095-9327</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU2L1DAYx4so7rr6AbxIjoK0JmleWgRBFnUXV7yo15AmT2cytElN0nHn25th1mW9eEog_5cnz6-qXhLcEEzE210zG99QTGSDeYNx_6g6J7jndd9S-fh4Z6yWrCVn1bOUdhhjTvv2aXVGO85py8h5dfsV8lbPyxaynp0HtIQMPjudIaGr65812SyE4tp5uxqwaHYmhs3k9IQ8rDHkcOsM0ia7vcsHNBwQ-K32xvnNQ21Y828dLfryBpk1xtLwvHoy6inBi7vzovrx6eP3y6v65tvn68sPN7VhnORadqPoZS-E6QQdtO4ZFpJRLWBgXFpsu5GbgQuhx4EUB6NitKKDURCrLTftRfX-lLuswwzWlOqoJ7VEN-t4UEE79e-Ld1u1CXtVNsRaKUvA67uAGH6tkLKaXTIwTdpDWJMiPW5Z23WiK1JykpZ_pxRhvK8hWB2JqZ0qxNSRmMJcFWLF8-rhfPeOv4iK4N1JAGVLewdRJePAFxgugsnKBvef-D-eEqny</recordid><startdate>20170701</startdate><enddate>20170701</enddate><creator>Liu, Jianuo</creator><creator>Xu, Enquan</creator><creator>Tu, Guihua</creator><creator>Liu, Han</creator><creator>Luo, Jiangtao</creator><creator>Xiong, Huangui</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170701</creationdate><title>Methamphetamine potentiates HIV-1gp120-induced microglial neurotoxic activity by enhancing microglial outward K+ current</title><author>Liu, Jianuo ; Xu, Enquan ; Tu, Guihua ; Liu, Han ; Luo, Jiangtao ; Xiong, Huangui</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-78f697966c862baa9406742a6eb457d0d8f5cb566afb1451426fd68ef61dad5c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Animals</topic><topic>Cells, Cultured</topic><topic>Drug abuse</topic><topic>Female</topic><topic>HIV Envelope Protein gp120 - metabolism</topic><topic>HIV protein</topic><topic>Methamphetamine - pharmacology</topic><topic>Microglia</topic><topic>Microglia - metabolism</topic><topic>Neurodegeneration</topic><topic>Neurons - metabolism</topic><topic>Potassium - metabolism</topic><topic>Rats, Sprague-Dawley</topic><topic>Signal Transduction - physiology</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><topic>Voltage-gated K channel</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Jianuo</creatorcontrib><creatorcontrib>Xu, Enquan</creatorcontrib><creatorcontrib>Tu, Guihua</creatorcontrib><creatorcontrib>Liu, Han</creatorcontrib><creatorcontrib>Luo, Jiangtao</creatorcontrib><creatorcontrib>Xiong, Huangui</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Molecular and cellular neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Jianuo</au><au>Xu, Enquan</au><au>Tu, Guihua</au><au>Liu, Han</au><au>Luo, Jiangtao</au><au>Xiong, Huangui</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Methamphetamine potentiates HIV-1gp120-induced microglial neurotoxic activity by enhancing microglial outward K+ current</atitle><jtitle>Molecular and cellular neuroscience</jtitle><addtitle>Mol Cell Neurosci</addtitle><date>2017-07-01</date><risdate>2017</risdate><volume>82</volume><spage>167</spage><epage>175</epage><pages>167-175</pages><issn>1044-7431</issn><eissn>1095-9327</eissn><abstract>Methamphetamine (Meth) abuse not only increases the risk of human immunodeficiency virus-1 (HIV-1) infection, but exacerbates HIV-1-associated neurocognitive disorders (HAND) as well. The mechanisms underlying the co-morbid effect are not fully understood. Meth and HIV-1 each alone interacts with microglia and microglia express voltage-gated potassium (KV) channel KV1.3. To understand whether KV1.3 functions an intersecting point for Meth and HIV-1, we studied the augment effect of Meth on HIV-1 glycoprotein 120 (gp120)-induced neurotoxic activity in cultured rat microglial cells. While Meth and gp120 each alone at low (subtoxic) concentrations failed to trigger microglial neurotoxic activity, Meth potentiated gp120-induced microglial neurotoxicity when applied in combination. Meth enhances gp120 effect on microglia by enhancing microglial KV1.3 protein expression and KV1.3 current, leading to an increase of neurotoxin production and resultant neuronal injury. Pretreatment of microglia with a specific KV1.3 antagonist 5-(4-Phenoxybutoxy)psoralen (PAP) or a broad spectrum KV channel blocker 4-aminopyridine (4-AP) significantly attenuated Meth/gp120-treated microglial production of neurotoxins and resultant neuronal injury, indicating an involvement of KV1.3 in Meth/gp120-induced microglial neurotoxic activity. Meth/gp120 activated caspase-3 and increased caspase-3/7 activity in microglia and inhibition of caspase-3 by its specific inhibitor significantly decreased microglial production of TNF-α and iNOS and attenuated microglia-associated neurotoxic activity. Moreover, blockage of KV1.3 by specific blockers attenuated Meth/gp120 enhancement of caspase-3/7 activity. Taking together, these results suggest an involvement of microglial KV1.3 in the mediation of Meth/gp120 co-morbid effect on microglial neurotoxic activity via caspase-3 signaling. •Meth potentiates gp120-induced microglial neurotoxic activity.•Meth potentiation of gp120 effect on microglia via K+ channel KV1.3 and caspase 3/7 signaling•Present results may imply a potential mechanism for HAND pathogenesis in the era of cART.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28552341</pmid><doi>10.1016/j.mcn.2017.05.009</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1044-7431
ispartof Molecular and cellular neuroscience, 2017-07, Vol.82, p.167-175
issn 1044-7431
1095-9327
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5524377
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Animals
Cells, Cultured
Drug abuse
Female
HIV Envelope Protein gp120 - metabolism
HIV protein
Methamphetamine - pharmacology
Microglia
Microglia - metabolism
Neurodegeneration
Neurons - metabolism
Potassium - metabolism
Rats, Sprague-Dawley
Signal Transduction - physiology
Tumor Necrosis Factor-alpha - metabolism
Voltage-gated K channel
title Methamphetamine potentiates HIV-1gp120-induced microglial neurotoxic activity by enhancing microglial outward K+ current
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T18%3A07%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Methamphetamine%20potentiates%20HIV-1gp120-induced%20microglial%20neurotoxic%20activity%20by%20enhancing%20microglial%20outward%20K+%20current&rft.jtitle=Molecular%20and%20cellular%20neuroscience&rft.au=Liu,%20Jianuo&rft.date=2017-07-01&rft.volume=82&rft.spage=167&rft.epage=175&rft.pages=167-175&rft.issn=1044-7431&rft.eissn=1095-9327&rft_id=info:doi/10.1016/j.mcn.2017.05.009&rft_dat=%3Cproquest_pubme%3E1903438868%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1903438868&rft_id=info:pmid/28552341&rft_els_id=S1044743116301312&rfr_iscdi=true